US 11912778
Methods of engineering transferrin receptor binding polypeptides
granted A61KA61K38/00
Quick answer
US patent 11912778 (Methods of engineering transferrin receptor binding polypeptides) held by DENALI THERAPEUTICS INC. expires Mon Feb 22 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- DENALI THERAPEUTICS INC.
- Grant date
- Tue Feb 27 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 22 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K38/00